SHAH RAJEEV M. purchased 39.8% of their position (1.33M shares) of SATSUMA PHARMACEUTICALS, INC. on the open market

Open‑market purchase worth $20.00M — a major conviction buy. The strongest form of insider conviction signal.

P · 2 purchases

SHAH RAJEEV M.

Filed: 9/17/2019ACC: 0000899243-19-023733

InsiderSHAH RAJEEV M.CIK 1619841

→

IssuerSATSUMA PHARMACEUTICALS, INC.CIK 1692830

Director10% Owner

Since Sep 2019

+1.33M

Net shares

Net buyer

$20.00M

Total acquired

Open market trades

2B · 0S

Total transactions

4.68M acquired · 3.35M disposed

Non-Derivative Transactions6

Common Stock, $0.0001 par value

Indirect

C · Conversion

+1.64M

Price / share

—

Trade value

—

% of position

New position

9/17/2019

0.00→1.64M

Common Stock, $0.0001 par value

Indirect

C · Conversion

+1.14M

Price / share

—

Trade value

—

% of position

69.4%

9/17/2019

1.64M→2.78M

Common Stock, $0.0001 par value

Indirect

C · Conversion

+365.53K

Price / share

—

Trade value

—

% of position

13.1%

9/17/2019

2.78M→3.15M

Common Stock, $0.0001 par value

Indirect

C · Conversion

+200.48K

Price / share

—

Trade value

—

% of position

6.4%

9/17/2019

3.15M→3.35M

Common Stock, $0.0001 par value

Indirect

P · Purchase

+1.14M

Price / share

$15.00

Trade value

$17.11M

% of position

34.1%

9/17/2019

3.35M→4.49M

Common Stock, $0.0001 par value

Indirect

P · Purchase

+192.39K

Price / share

$15.00

Trade value

$2.89M

% of position

4.3%

9/17/2019

4.49M→4.68M

Total

Net shares

+4.68M

Net value

$20M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock, $0.0001 par value Indirect	9/17/2019	C · Conversion	+1.64M	—	—	New position	0.00	1.64M
Common Stock, $0.0001 par value Indirect	9/17/2019	C · Conversion	+1.14M	—	—	69.4%	1.64M	2.78M
Common Stock, $0.0001 par value Indirect	9/17/2019	C · Conversion	+365.53K	—	—	13.1%	2.78M	3.15M
Common Stock, $0.0001 par value Indirect	9/17/2019	C · Conversion	+200.48K	—	—	6.4%	3.15M	3.35M
Common Stock, $0.0001 par value Indirect	9/17/2019	P · Purchase	+1.14M	$15.00	$17.11M	34.1%	3.35M	4.49M
Common Stock, $0.0001 par value Indirect	9/17/2019	P · Purchase	+192.39K	$15.00	$2.89M	4.3%	4.49M	4.68M
Total			+4.68M		$20M

Derivative Transactions4

Series A Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

1.64M shares

−1.64M

Strike price

Held after

0.00

Exercisable

—

9/17/2019

Series A Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

365.53K shares

−365.53K

Strike price

Held after

0.00

Exercisable

—

9/17/2019

Series B Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

1.14M shares

−1.14M

Strike price

Held after

0.00

Exercisable

—

9/17/2019

Series B Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

200.48K shares

−200.48K

Strike price

Held after

0.00

Exercisable

—

9/17/2019

Security	Converts To	Date	Type	Shares	Exercisable
Series A Preferred Stock Indirect	Common Stock1.64M shares	9/17/2019	C · Conversion	−1.64M	—
Series A Preferred Stock Indirect	Common Stock365.53K shares	9/17/2019	C · Conversion	−365.53K	—
Series B Preferred Stock Indirect	Common Stock1.14M shares	9/17/2019	C · Conversion	−1.14M	—
Series B Preferred Stock Indirect	Common Stock200.48K shares	9/17/2019	C · Conversion	−200.48K	—